FDA Inspection 907753 — Cooper Institute For Advanced Reproductive Medicine

Cooper Institute For Advanced Reproductive Medicine — FEI 3011006339

The FDA completed an inspection of Cooper Institute For Advanced Reproductive Medicine on Dec 22, 2014 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 22, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Houston, TX (United States)

Citations

IDCFRDescription
1228621 CFR 1271.80(b)Specimen collections not timely

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.